目的 探讨重性抑郁障碍(MDD)患者肠道菌群特征与选择性5-羟色胺再摄取抑制剂(SSRIs)疗效的关联性, 筛选可预测SSRIs疗效的肠道菌群生物标志物。方法 选取2024年5月—2025年5月宁夏回族自治区人民医院收治的90例MDD患者, 根据SSRIs治疗8周后疗效分为应答组56例和无应答组34例, 并选择30例健康对照, 采集基线粪便样本进行16S rRNA基因测序, 分析肠道菌群α多样性、菌属相对丰度差异,并通过相关性分析、多因素Logistic回归及ROC曲线评估菌群标志物对SSRIs疗效的预测价值。结果 MDD患者肠道菌群Chao1指数、Shannon指数低于健康对照(P<0.05), 应答组与无应答组α多样性无差异(P>0.05)。应答组基线Blautia、双歧杆菌属、粪球菌属丰度高于无应答组(P<0.05), 大肠杆菌-志贺菌属丰度低于无应答组(P<0.05)。基线Blautia、双歧杆菌属、粪球菌属丰度与SSRIs治疗8周HAMD-17减分率呈正相关(r分别为0.390、0.420、0.350,均P<0.05), 三者联合预测SSRIs疗效的ROC曲线下面积(AUC)为0.910(灵敏度83.9%,特异度85.3%)。结论 MDD患者存在肠道菌群结构异常, 基线Blautia、双歧杆菌属、粪球菌属丰度可作为SSRIs疗效的潜在预测标志物,为MDD个体化治疗提供实验依据。
Objective To explore the association between gut microbiota characteristics and the efficacy of selective serotonin reuptake inhibitors(SSRIs)in patients with major depressive disorder(MDD), and to screen gut microbiota biomarkers for predicting SSRIs efficacy.Methods A total of 90 MDD patients(divided into responders[n=56] and non-responders[n=34] based on 8-week SSRIs efficacy)and 30 healthy controls were enrolled from May 2024 to May 2025.Fecal samples were collected for 16S rRNA gene sequencing to analyze gut microbiota α diversity and genus-level relative abundance.Correlation analysis, multivariate logistic regression, and receiver operating characteristic curve were used to evaluate the predictive value of microbiota markers for SSRIs efficacy.Results The Chao1 and Shannon indices of gut microbiota in MDD patients were significantly lower than those in healthy controls(P<0.05), with no difference between responders and non-responders(P>0.05).Responders had higher baseline abundances of Blautia,Bifidobacterium, and Coprococcus(P<0.05), and lower abundance of Escherichia-Shigella compared to non-responders.Baseline abundances of Blautia,Bifidobacterium(P<0.05), and Coprococcus were positively correlated with 8-week HAMD-17 reduction rate(r=0.390, 0.420, 0.350; all P<0.05).The combined prediction of these three genera for SSRIs efficacy showed an area under the curve of 0.910(sensitivity 83.9%, specificity 85.3%).Conclusions MDD patients exhibit abnormal gut microbiota structure.Baseline abundances of Blautia,Bifidobacterium, and Coprococcus may serve as potential predictive biomarkers for SSRIs efficacy, providing experimental basis for personalized treatment of MDD.
目的 探究四子散中药封包药熨在股骨骨折术后疼痛及肿胀中的临床疗效及安全性。方法 选取2024年6月—2025年5月婺源县人民医院骨科收治的60例股骨骨折术后患者, 随机分为观察组(30例,常规治疗+四子散中药封包药熨)与对照组(30例,常规治疗)。比较两组治疗前后疼痛评分(NRS-11)、肿胀程度评分、C反应蛋白(CRP)、白细胞介素-6(IL-6)水平及不良事件发生率。结果 治疗前两组患者疼痛、肿胀评分、CRP、IL-6水平比较差异无统计学意义(P>0.05); 治疗1周后,观察组疼痛评分为(2.11±0.48)分、肿胀程度为(0.35±0.43)度、CRP为(12.23±3.12)mg/L、IL-6为(16.03±4.01)ng/L,均低于对照组的(3.54±0.56)分、(1.04±0.58)度、(24.31±4.51)mg/L、(23.19±6.75)ng/L,差异有统计学意义(P<0.001)。观察组与对照组均无发生不良事件。结论 四子散中药封包药熨可缓解股骨骨折术后疼痛及肿胀,安全性良好。
Objective To explore the clinical efficacy and safety of Sizi powder pack hot compress in the treatment of pain and swelling after femoral fracture surgery.Methods From June 2024 to May 2025, 60 patients after femoral fracture surgery were admitted to the Orthopedics Department of Wuyuan County People's Hospital and randomly divided into observation group(30 cases, conventional treatment+Sizi power pack hot compress)and control group(30 cases, conventional treatment). The pain score(NRS-11), swelling score, CRP,IL-6 levels and incidence of adverse events before and after treatment were compared between the two groups.Results There was no significant difference in pain and swelling scores between the two groups before treatment(P>0.05).After 1 week of treatment, the pain score(2.11±0.48), swelling score(0.35±0.43), CRP(12.23±3.12 mg/L), IL-6(16.03±4.01 ng/L)levels in the observation group were significantly lower than those in the control group(3.54±0.56, 1.04±0.58, 24.31±4.51 mg/L, 16.03+4.01 ng/L), and the difference was statistically significant(P<0.001).There were no adverse events in the observation group or the control group.Conclusions Sizi power pack hot compress can significantly alleviate the pain and swelling after femoral fracture surgery,and with good safety.
目的 研究非酒精性脂肪肝老年人体质辨识及中医治未病服务对其治疗效果。方法 选择2023年1月—2024年1月贵州中医药大学第一附属医院就诊的非酒精性脂肪性肝病老年患者70例作为研究对象,根据患者就诊顺序分配为两组。对照组35例,接受常规干预;观察组35例,其在对照组基础上予中医“治未病”理念下体质辨识干预模式。比较两组干预效果,以及干预前后血脂水平、肝功能、生存质量的变化。结果 观察组的治疗总有效率91.43%,高于对照组的68.57%,差异有统计学意义(P<0.05)。治疗前,两组各项血脂水平、肝功能、慢性肝病问卷(CLDQ)评分比较,差异无统计学意义(P>0.05);治疗后,两组各项血脂水平优于治疗前,各项肝功能低于治疗前,CLDQ评分高于治疗前,差异有统计学意义(P<0.05);治疗后,观察组的各项血脂水平优于对照组,各项肝功能低于对照组,CLDQ评分高于对照组,差异有统计学意义(P<0.05)。结论 对非酒精性脂肪性肝病老年患者而言,中医“治未病”理念下体质辨识干预服务能够提高其治疗效果,调节血脂水平的异常,改善肝功能及生存质量,值得应用。
Objective To study the physical identification of nonalcoholic fatty liver in the elderly and the therapeutic effect of traditional Chinese medicine on preventing disease before arising.Methods A total of 70 elderly patients with nonalcoholic fatty liver disease treated in the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine from January 2023 to January 2024 were selected as the study objects.Patients were assigned to two groups,control group(35 cases)received routine intervention,observation group(35 cases)received physical identification intervention based on preventing disease before arising of traditional Chinese medicine additionally.The effect of intervention and the changes of blood lipid levels,liver function and quality of life before and after intervention were compared between the two groups.Results The total effective rate of the observation group was 91.43%,higher than that of the control group(68.57%),the difference was statistically significant(P<0.05).Before treatment,there were no significant differences in blood lipid levels,liver function and CLDQ scores between the two groups(P>0.05).After treatment,the levels of blood lipids were better than those before treatment,liver function was lower than that before treatment,CLDQ score was higher than that before treatment,the difference was statistically significant(P<0.05).After treatment,the blood lipid levels of the observation group was better than that of the control group,the liver function was lower than that of the control group,and the CLDQ score was higher than that of the control group,with statistical significance(P<0.05).Conclusions For elderly patients with nonalcoholic fatty liver disease,the intervention service of body constitution identification under the concept of preventing disease before arising of traditional Chinese medicine can improve the therapeutic effect,regulate the abnormal blood lipid levels,improve liver function and quality of life,which is worthy of application.
目的 分析广州番禺地区鹦鹉热衣原体肺炎患者临床表现、实验室及胸部CT特征、并发症以及治疗方案,为其临床诊治提供参考。方法 回顾性分析2022年1月—2024年7月在广州市番禺区何贤纪念医院通过二代测序技术确诊的10例鹦鹉热感染患者的临床资料。结果 5例(5/10)患者有明确的鸟类或禽类接触史,8例(8/10)患者以发热为首发症状,发热(10/10)、咳嗽、咳痰(10/10)、呼吸困难(7/10)、相对缓脉(8/10)是主要临床表现。患者白细胞计数通常正常或轻微升高;多数患者存在有不同程度的电解质紊乱(10/10)及肝功能损伤(8/10)、乳酸脱氢酶升高(8/10),白蛋白显著降低(8/10)和C反应蛋白显著升高(10/10)。最常见的胸部CT异常为多肺叶受累的斑片状或片状实变,而重症患者多合并双侧胸腔积液。大多数患者经四环素或喹诺酮类单用,或者四环素联用β-内酰胺类抗菌药物治疗,预后良好。结论 有鸟类或禽类接触史、以发热为首发或主要症状、存在相对缓脉、白细胞计数升高不明显等临床特征可有助于区分鹦鹉热衣原体肺炎与其他传统细菌性肺炎,但这并不能确诊。二代测序技术是确诊鹦鹉热衣原体感染的很好方法,可以缩短诊断延误时间并改善患者预后。
Objective To describe the clinical,laboratory and chest CT characteristics as well as the complications and treatments of Chlamydia psittaci pneumonia patients in Panyu district of Guangzhou,to provide reference for clinical diagnosis and treatment.Methods A retrospective study was conducted on the clinical characteristics of Chlamydia psittaci pneumonia patients who were diagnosed by next-generation sequencing in Panyu Hexian Memorial Hospital of Guangzhou form January 2022 to July 2024.Results Half patients had a definite history of bird or poultry exposure.Fever(100%),cough,sputum(100%),dyspnea(70%),relative bradycardia(80%)were the main clinical presentation.The total white cell counts were usually normal or slightly increased.Most patients had electrolyte disturbance(100%),liver function impairment(80%),lactic dehydrogenase increased(80%),albumin decreased(80%)and C reactive protein increased remarkably(100%).The most common chest CT abnormality was patchy or flaky hyper densities and consolidation,bilateral pleural effusion was common in severe patients.All patient exhibited good recovery after being treated with tetracycline or quinolone alone,or tetracycline in combination with other antibiotics.Conclusions These characteristics may help distinguish Chlamydia psittaci pneumonia from other traditional bacterial pneumonia,but they are not definitive.Next-generation sequencing may be a promising approach to confirm Chlamydia psittaciinfection,which can shorten the diagnostic delay time and improve the prognosis of patients.
目的 探讨口服水合氯醛与鼻内给予右美托咪定中深度镇静下行泪道探通术治疗婴幼儿先天性泪道阻塞的疗效、并发症及安全性。方法 随机选择2021年2月—2023年6月在广州医科大学附属妇女儿童医疗中心就诊的先天性泪道阻塞患儿,将其分为观察组和对照组,观察组行中深度镇静后进行泪道探通术,对照组进行表麻下泪道探通术,对比两组的治愈率及并发症发生率。结果 观察组共76例(97眼),总治愈率98.97%,分为3组,6~12月龄组41例(53眼),12~18月龄组14例(15眼),18~36月龄组21例(29眼),对照组共84例(116眼),总治愈率93.10%,6~12月龄组55例(70眼),12~18月龄组15例(24眼),18~36月龄14例(22眼),观察组泪道探通术治愈率高于对照组,差异有统计学意义(χ 2 =4.49,P<0.05)。观察组一次探通的成功率为92.78%,高于对照组61.21%,差异有统计学意义(χ 2 =26.86,P<0.05)。观察组二次探通的成功率为85.71%,高于对照组44.44%,差异有统计学意义(χ 2 =4.13,P<0.05)。发生的并发症主要是出血、皮下水肿、感染、假道形成,观察组并发症的发生率4.12%,低于对照组15.52%,差异有统计学意义(χ 2 =7.40,P<0.05)。观察组中2例患儿口服水合氯醛出现恶心呕吐,改为右美托咪定滴鼻。3例患儿右美托咪定滴鼻后出现口唇苍白,持续10~15 min即可缓解。其余均未有不良反应。结论 中深度镇静下给予婴幼儿泪道阻塞患儿行泪道探通术相比传统表麻下泪道探通术疗效更好,并发症较少,对孩子的心理创伤小,安全且经济实惠。
Objective To explore the efficacy,complications and safety of moderate and deep sedation under oral administration of chloral hydrate and intranasal administration of dexmedetomidine for the treatment of congenital nasolacrimal duct obstruction(CNLDO) in infants and young children.Methods Children with CNLDO who visited our hospital from February 2021 to June 2023 were randomly selected and divided into the observation group and the control group.The observation group was performed with lacrimal duct probing after moderate and deep sedation,while the control group was performed with lacrimal duct probing under surface anesthesia.The cure rate and incidence of complications were compared between the two groups.Adverse reactions after using sedatives were observed.Results The observation group consisted of 76 cases(97 eyes),with a total cure rate of 98.97%.They were divided into three groups:41 cases(53 eyes)in the aged 6-12 months group,14 cases(15 eyes)in the aged 12-18 months group,and 21 cases(29 eyes)in the aged 18-36 months group.The control group consisted of 84 cases(116 eyes),with a total cure rate of 93.10%.There were 55 cases(70 eyes)in the aged 6-12 months group,15 cases(24 eyes)in the aged 12-18 months group,and 14 cases(22 eyes)in the aged 18-36 months group.The cure rate of lacrimal duct probing in the observation group was significantly higher than that in the control group(χ 2 =4.49,P<0.05).The success rate of the first probing in the observation group was 92.78%,significantly higher than that in the control group of 61.21%(χ 2 =26.86,P<0.05).The success rate of the second probing in the observation group was 85.71%,significantly higher than that in the control group of 44.44%(χ 2 =4.13,P<0.05).The incidence of complications mainly were bleeding,subcutaneous edema,infection,and false passage formation.The incidence of complications in the observation group was 4.12%,lower than that in the control group 15.52%,and the difference was statistically significant(χ 2 =7.40,P<0.05).Two cases in the observation group experienced nausea and vomiting after taking chloral hydrate orally,and were replaced with dexmedetomidine nasal drops.Three cases of pediatric patients showed pale lips after nasal administration of dexmedetomidine,which lasted for 10-15 minutes and could be relieved.No other adverse reactions were observed.Conclusions Under moderate and deep sedation,lacrimal duct probing treatment for infants and young children with CNLDO showed better therapeutic effects,fewer complications,less psychological trauma to these patients,which is safe and cost-effective,and is suitable for promotion compared to under traditional surface anesthesia.
目的 探究本体感觉神经肌肉促进疗法(PNF)技术与居家远程康复治疗对缺血性脑卒中患者凝血功能、平衡状态的影响。方法 选择2023年1月—2024年1月在宁乡市中医医院择期治疗的60例缺血性脑卒中患者为研究对象。按照患者选择的治疗方案进行分组, 观察组接受PNF技术联合居家远程康复指导治疗, 对照组接受常规居家远程康复指导治疗。记录疗效、凝血功能、神经功能缺损症状。结果 凝血功能方面,观察组治疗后活化部分凝血酶时间(APTT)、凝血酶原时间(PT)高于治疗前, 二聚体(D-D)、纤维蛋白原(FIB)低于治疗前,组间比较差异有统计学意义(P<0.05)。与对照组相比, 观察组的APTT、PT、D-D、FIB指标相近,组间比较差异无统计意义(P>0.05)。治疗后, 观察组平衡功能(BBS)评分比治疗前高, 组间比较差异有统计学意义(P<0.05)。观察组BBS评分、FMA评分、肌力等级更高, 组间比较差异有统计学意义(P<0.05)。结论 PNF技术+居家远程康复指导治疗可作为缺血性脑卒中患者治疗的有效手段。联合治疗后凝血功能、平衡状态、肢体功能状况、肌力明显改善, 可见联合治疗对于减轻患者病情尤为明显。
Objective To explore the effects of proprioceptive neuromuscular facilitation(PNF)and home-based remote rehabilitation on coagulation function and balance function in patients with ischemic stroke.Methods From January 2023 to January 2024, 60 patients with ischemic stroke were selected from our hospital.The patients were divided into two groups according to the treatment plan chosen by themselves.The patients in the observation group received PNF technology combined with home-based remote rehabilitation guidance, while the patients in the control group received routine home-based remote rehabilitation guidance.The curative effect, coagulation function and neurological deficit were recorded.Results After treatment, activated partial thrombin time(APTT)and prothrombin time(PT)were significantly higher, D-dimer(D-D)and fibrinogen(FIB)were significantly lower in the observation group than those before treatment(P<0.05).Compared with the control group, the APTT, PT, D-D and FIB of the observation group were similar, and there was no significant difference between the two groups(P>0.05).After treatment, the Berg Balance Scale score of the observation group was higher than that before treatment, and there was significant difference between the two groups(P<0.05).The Berg Balance Scale score, Fugl-Meyer Assessment score and muscle strength grade of observation group were higher than those of control group(P<0.05).Conclusions PNF combined with home-based remote rehabilitation can be used as an effective method for the treatment of patients with ischemic stroke.The coagulation function, balance, extremity function and muscle strength were significantly improved after combined treatment, which indicated that the combined treatment was especially effective in relieving the patients’ symptoms.
目的 探讨作业疗法结合经皮神经电刺激对脑卒中后肩痛的疗效。方法 选取2020年6月—2023年6月在肇庆市第一人民医院治疗的60例脑卒中后肩痛患者为研究对象,随机分为观察组和对照组各30例。其中,观察组进行作业疗法结合经皮神经电刺激;对照组单纯进行作业疗法。记录患者治疗前及治疗4周后的视觉模拟疼痛评分(VAS),改良Barthel指数(MBI)和汉密顿抑郁量表评分(HAMD),并对记录进行检验和t检验。结果 观察组和对照组的治疗效果比较差异有统计学意义(P=0.019),观察组治疗有效率(93.33%)高于对照组(63.33%);治疗前两组患者的VAS(P=0.536)和HAMD(P=0.558)分值比较差异无统计学意义,治疗后其VAS(P=0.049)及HAMD(P=0.023)分值均较治疗前下降,且观察组下降幅度分别为(2.23±1.14)分和(4.47±3.06)分,均高于对照组的(1.27±0.98)和(1.33±1.35),组间比较差异有统计学意义;治疗前两组患者的MBI分值比较差异无统计学意义(P=0.216),治疗后其MBI分值均较治疗前提高,且观察组提高幅度(21.87±10.25)较对照组(12.00±13.58)更显著,组间比较差异有统计学意义(P=0.003)。结论 作业疗法结合经皮神经电刺激可缓解脑卒中肩痛,改善患者日常生活能力和心理精神状态,减少抑郁的发生。
Objective To explore the therapeutic effect of occupational therapy combined with transcutaneous electrical nerve stimulation(TENS) on shoulder pain after stroke.Methods Sixty patients with post-stroke shoulder pain who were treated in the First People’s Hospital of Zhaoqing from June 2020 to June 2023 were selected as the study subjects and randomly divided into an observation group and a control group,with 30 cases in each group.Among them,the observation group received occupational therapy combined with TENS,while the control group received occupational therapy alone.This study recorded the Visual Analogue Scale(VAS),modified Barthel Index(MBI),and Hamilton Depression Rating Scale(HAMD)of patients before and after 4 weeks of treatment,and conducted the and t-test analysis.Results The test analysis showed a significant difference in treatment effectiveness between the observation group and the control group(P=0.019),with the observation group having a significantly higher treatment effectiveness rate(93.33%)than the control group(63.33%);t-test analysis showed that there was no statistically significant difference in VAS(P=0.536)and HAMD(P=0.558)indicators between the two groups of patients before treatment.However,after treatment,the VAS(P=0.049)and HAMD(P=0.023)indicators decreased compared to before treatment.The observation group had decreased(2.23±1.14)and(4.47±3.06),respectively,which were significantly higher than the control group’s(1.27±0.98)and(1.33±1.35),and the inter group differences were statistically significant;before treatment,there was no statistically significant difference in MBI indicators between the two groups of patients(P=0.216).After treatment,their MBI indicators increased compared to before treatment,and the observation group(21.87±10.25)showed a more significant improvement compared to the control group(12.00±13.58).The difference between the groups was statistically significant(P=0.003).Conclusions Occupational therapy combined with TENS can significantly alleviate shoulder pain after stroke,improve daily living ability and psychological state of patients,and reduce the occurrence of depression.
目的 探究伏诺拉生三联疗法根除幽门螺杆菌(Hp)的疗效。方法 入组2022年5月—12月经13C尿素呼气试验确诊的Hp现症感染者200例,分为观察组和对照组,每组100例。观察组方案为阿莫西林、呋喃唑酮、伏诺拉生三联疗法,对照组方案为阿莫西林、呋喃唑酮、艾司奥美拉唑镁、枸橼酸铋钾四联疗法;疗程均为14 d。在治疗停药后1个月复查13C尿素呼气试验判定是否Hp根除成功,并观察药物不良反应发生率。结果 观察组Hp根除率为96.97%,高于对照组的89.80%,差异有统计学意义(P<0.05);观察组不良反应发生率和对照组比较差异无统计学意义(P>0.05)。结论 伏诺拉生、阿莫西林、呋喃唑酮三联疗法的Hp根除率较高且安全性良好,可作为Hp感染的治疗方案之一。
Objective To explore the effect of vonoprazan triple therapy on Helicobacter pylori(Hp).Methods A total of 200 patients with Hp infection confirmed by 13C urea breath test from May-December 2022 were selected and divided into observation group and control group with 100 patients in each group.The observation group was treated with triple therapy of amoxicillin,furazolidone and vonoprazan,while the control group was treated with quadruple therapy of amoxicillin,furazolidone,esomeprazole magnesium and bismuth potassium citrate.The treatment course was 14 days.The 13C urea breath test was reviewed one month after treatment withdrawal to determine whether Hp eradication was successful,and the incidence of adverse drug reactions was observed.Results The eradication rate of Hp in the observation group was 96.97%,higher than 89.80% in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusions The triple therapy of vonoprazan,amoxicillin and furazolidone has a very high eradication rate and good safety,which can be used as one of the treatment options for Hp.
目的 探讨丙戊酸钠联合奥卡西平治疗癫痫的疗效及其对患者炎性因子的影响。方法 选择2022年1月—2023年1月医院接收的100例癫痫患者进行研究,电脑随机编号奇偶数分为两组各50例,对照组采取丙戊酸钠治疗,观察组采取丙戊酸钠联合奥卡西平治疗,评价并比较两组治疗效果、神经因子、炎症因子、免疫功能、认知功能及生活质量,观察不良反应发生率。结果 观察组和对照组的治疗有效分别为47例(94.00%)、39例(78.00%),观察组治疗有效率高于对照组(χ2=5.315,P=0.02)。治疗后,观察组的脑源性神经营养因子(195.33±18.29)pg/mL、神经生长因子(594.69±54.45)ng/mL水平高,肿瘤坏死因子-α(4.12±1.07)pg/mL、IL-1β(3.48±0.79)pg/mL、IL-6(53.44±3.63)pg/mL水平比对照组(150.68±15.27)pg/mL、(542.46±45.56)ng/mL、(6.35±1.27)pg/mL、(4.35±0.93)pg/mL、(63.02±3.81)pg/mL低(t=13.250、5.201、9.495、5.041、12.872,P<0.05)。治疗后,观察组的IgM(1.02±0.12)g/L、IgG(10.02±1.22)g/L、IgA(2.10±0.22)g/L比对照组(1.13±0.14)g/L、(11.68±1.57)g/L、(2.65±0.31)g/L更高(t=4.218、5.903、10.230,P<0.05)。治疗后,观察组的蒙特利尔认知量表(27.78±2.15)分、日常生活活动量表(71.88±6.45)分、癫痫患者生活质量评定量表-31(82.65±8.25)分比对照组(25.33±2.01)分、(65.65±5.54)分、(74.05±7.37)分更高(t=5.886、5.181、5.497,P<0.05)。观察组、对照组发生不良反应组间比较差异无统计学意义(χ2=1.010,0.343,1.010,1.010,1.010,P均>0.05)。结论 丙戊酸钠联合奥卡西平治疗癫痫患者可取得良好的疗效,控制癫痫症状,改善神经因子、认知功能,增强免疫功能,控制炎症因子,而且不良反应少,利于生活质量提高。
Objective To investigate the effect of sodium valproate combined with oxcarbazepine in the treatment of epilepsy and its influence on inflammatory factors.Methods From January 2022 to January 2023,100 patients with epilepsy admitted to our hospital were selected and randomly divided into two groups,50 cases in each group.The control group was treated with sodium valproate,and the observation group was treated with sodium valproate combined with oxcarbazepine.The therapeutic effect,neurological factors,inflammatory factors,immune function,cognitive function and quality of life were evaluated and compared between the two groups,and the incidence of adverse reactions was observed.Results The effective rate of the observation group and the control group were 94.00%(47 cases)and 78.00%(39 cases),respectively.The effective rate of the observation group was higher than that of the control group(χ2=5.315,P=0.02).After treatment,the levels of brain-derived neurotrophic factor(195.33±18.29)pg/mL and nerve growth factor(594.69±54.45)ng/mL in the observation group were higher than those in the control group.The levels of tumor necrosis factor-α(4.12±1.07)pg/mL,IL-1β(3.48±0.79)pg/mL,IL-6(53.44±3.63)pg/mL in the control group were(150.68±15.27)pg/mL,(542.46±45.56)ng/mL,(6.35±1.27)pg/mL,(4.35±0.93)pg/mL,(63.02±3.81)pg/mL(t=13.250,5.201,9.495,5.041,12.872,P<0.05). After treatment,the IgM(1.02±0.12)g/L,IgG(10.02±1.22)g/L,IgA(2.10±0.22)g/L were higher than those in the control group(1.13±0.14)g/L,(11.68±1.57)g/L,(2.65±0.31)g/L(t=4.218,5.903,10.230,P<0.05).After treatment,the scores of Montreal Cognitive Scale(27.78±2.15),Activities of Daily Living Scale(71.88±6.45)and Quality of Life in Epilepsy Scale 31(82.65±8.25)in the observation group were higher than those in the control group(25.33±2.01),(65.65±5.54)and(74.05±7.37)(t=5.886,5.181,5.497,P<0.05).There was no significant difference in adverse reactions between the observation group and the control group(χ2=1.010,0.343,1.010,1.010,1.010,all P>0.05).Conclusions Sodium valproate combined with oxcarbazepine in the treatment of patients with epilepsy can achieve good curative effect,control epilepsy symptoms,improve neurological factors,cognitive function,enhance immune function,control inflammatory factors,with less adverse reactions,conducive to improve the quality of life.
目的 探讨盆底磁刺激联合生物反馈治疗女性膀胱过度活动症的疗效。方法 选择2022年8月—2023年7月福建医科大学附属福州市第一医院妇科接收的女性膀胱过度活动症患者90例为研究对象,以随机数字表法分为两组,每组各45例,对照组采取常规药物及康复治疗,观察组在此基础上给予盆底磁刺激联合生物反馈治疗,比较两组治疗效果、排尿功能、尿流动力学及生活质量。结果 观察组治疗有效率43例(95.56%)高于对照组36例(80.00%)(χ2=5.074,P=0.024)。治疗后观察组白天排尿次数(7.22±2.25)次、夜间排尿次数(2.05±0.44)次、尿急(1.54±0.48)次、急迫性尿失禁(1.22±0.25)次,低于对照组相应的(10.01±2.84)(3.32±0.84)(2.52±0.92)(2.24±0.39)次(t=5.165、8.984、6.335、14.770,P<0.05)。治疗后观察组初始尿意膀胱容量(188.45±24.43)mL、最大膀胱测压容积(320.42±25.49)mL,高于对照组的(155.54±20.06)(272.26±21.16)mL,膀胱顺应性(40.15±4.06)mL/cmH2O、残余尿量(82.25±8.45)mL,低于对照组的(50.05±5.54)mL/cmH2O、(125.44±12.26)mL(t=6.983、9.751、9.669、19.457,P<0.05)。治疗后观察组I-QOL(72.25±7.46)分,高于对照组(63.63±6.05)分(t=6.020,P<0.05)。结论 针对女性膀胱过度活动症患者采取盆底磁刺激联合生物反馈治疗可取得良好的治疗效果,减少患者排尿次数和残余尿量,改善尿急、尿失禁症状,恢复正常的尿流动力学,提高生活质量。